Bavituximab, CAS 648904-28-3

Product Description: Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity. Bavituximab plus Paclitaxel (HY-B0015) and Carboplatin (HY-17393), have enhanced inhibition on non-small-cell lung cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Digumarti R, et al. Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer. Lung Cancer. 2014 Nov;86(2):231-6. /[2]Cheng X, et al. Antibody-Mediated Blockade of Phosphatidylserine Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinomas Xenografts. Ann Surg Oncol. 2016 Dec;23(Suppl 5):583-591.

CAS Number: 648904-28-3

Molecular Weight: 145.3 (kDa)

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99279-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99279-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK